Statistical methods for assessing differential vaccine protection against human immunodeficiency virus types

Biometrics

Volumn 54, Issue 3, 1998, Pages 799-814

  Gilbert, Peter B ^a   Self, Steven G ^b   Ashby, Mark A ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c GENENTECH INC   (United States)

Author keywords

Cumulative logit model; Generalized logistic regression model; HIV vaccine efficacy trial; Human immunodeficiency virus; Multinomial logistic regression model; Sieve analysis; Stereotype model

Indexed keywords

DISEASES; REGRESSION ANALYSIS; VIRUSES;

CUMULATIVE LOGIT MODEL; GENERALIZED LOGISTIC REGRESSION MODEL; HIV VACCINE EFFICACY TRIAL; HUMAN IMMUNODEFICIENCY VIRUS; LOGISTIC REGRESSION MODELING; LOGIT MODELS; MULTINOMIAL LOGISTIC REGRESSION MODELS; SIEVE ANALYSIS; STEREOTYPE MODEL; VACCINE EFFICACIES;

VACCINES;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; DRUG EFFICACY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFECTION PREVENTION; STATISTICAL ANALYSIS; STATISTICAL MODEL; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031702866     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2533835     Document Type: Article

References (39)

1. Agresti, A. (1984). Analysis of Ordinal Categorical Data. New York: John Wiley.
2. Agresti, A. (1990). Categorical Data Analysis. New York: John Wiley.
3. AIDS Vaccine Evaluation Group. (1992). Protocol 201. A phase II trial to evaluate the immunogenicity and reactogenicity of the recombinant subunit HIV-1 envelope vaccine SF-2 RGP 120 in MF59 (Biocine) and MN RGP120 in alum in high risk population. Technical Report, Genentech, South San Francisco.
4. Anderson, J. A. (1972). Separate sample logistic discrimination. Biometrika 59, 19-35.
5. Anderson, J. A. (1983). Robust inference using logistic models. Bulletin of International Statistics Institute 48(2), 35-53.
6. Anderson, J. A. (1984). Regression and ordered categorical variables (with discussion). Journal of the Royal Statistical Society, Series B 46, 1-30.
7. Arendrup, M., Sonnerborg, A., Svennerholm, B., Akerblom, L., Nielsen, C., Clausen, H., Olofsson, S., Nielsen, J. O., and Hansen, J. E. (1993). Neutralizing antibody response during human immunodeficiency virus type 1 infection: Type and group specificity and viral escape. Journal of General Virology 74, 855-863.
8. Armitage, P. (1971). Statistical Methods in Medical Research. Oxford: Blackwell Scientific.
9. Berman, P. W., Matthews, T. J., Riddle, L., Champe, M., Hobbs, M. R., Nakamura, G. R., Mercer, J., Eastman, D. J., Lucas, C., and Langlois, A. J. (1992). Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1. Journal of Virology 66, 4464-4469.
10. Berman, P. W., Murthy, K. K., Wrin, T., et al. (1996a). Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1. Journal of Infectious Diseases 173, 52-59.
11. Berman, P. W., Gray, A., Ashby, M., Eastman, D., Wrin, T., Vennari, J. A., Francis, D., Gregory, T., Fast, P., Schwartz, D., Gorse, G., and McElrath, M. J. (1996b). Genetic and immunologic characterization of viruses infecting MN-rgp 120 vaccinated volunteers. Journal of Infectious Diseases 176, 384-397.
12. Breslow, N. E. and Day, N. E. (1980). Statistical Methods in Cancer Research, Volume 1. Lyon: International Agency for Research on Cancer.
13. Cao, H., Kanki, P., Sankale, J. L., Dieng-Sarr, A., Mazzara, G. P., Kalams, S. A., Korber, B., Mboup, S., and Walker, B. D. (1997). Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. Journal of Virology 71, 8615-8623.
14. Cohen, J. (1995). Thailand weighs AIDS vaccine tests. Science 270, 904-907.
15. Cox, D. R. (1970). The Analysis of Binary Data. London: Methuen.
16. Gilbert, P. B., Lele, S. R., and Vardi, Y. (1998). Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials. Biometrika, in press.
17. Girard, M., Meignier, B., Barr'e-Sinoussi, F., et al. (1995). Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. Journal of Virology 69, 6239-6248.
18. Hirji, K. F. (1992). Computing exact distributions for polytomous response data. Journal of the American Statistical Association 87, 487-492.
19. Koch, G. G., Landis, J. R., Freeman, J. L., Freeman, D. H., and Lehnen, R. G. (1977). A general methodology for the analysis of experiments with repeated measures of categorical data. Biometrics 33, 133-158.
20. Koziol, J. A. and Perlman, M. D. (1978). Combining independent chi-squared tests. Journal of the American Statistical Association 73, 753-763.
21. LaRosa, G. J., Davide, J. P., Weinhold, K., et al. (1990). Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249, 932-935.
22. Lasky, L. A., Groopman, J. E., Fennie, C. W., Benz, P. M., Capon, D. J., Dowbenko, D. J., Nakamura, G. R., Nunes, W. M., Renz, M. E., and Berman, P. W. (1986). Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science 233, 209-212.
23. Mascola, J. R., Snyder, S. W., Weislow, O. S., et al. (1996). Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. Journal of Infectious Diseases 173, 340-348.
24. McCullagh, P. (1980). Regression models for ordinal data (with discussion). Journal of the Royal Statistical Society, Series B 42, 109-142.
25. Mehta, C. and Patel, N. (1995). StatXact 3 for Windows. Cambridge, Massachusetts: Cytel Software.
26. Myers, G., Rabson, A. B., Berzofsky, J. A., Smith, T. F., and Wong-Staal, F. (1992). Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Retroviruses and AIDS Database, Los Alamos National Laboratory, Los Alamos, New Mexico.
27. Nkengasong, J. N., Peeters, M., Ndumbe, P., Janssens, W., Willems, B., Fransen, K., Ngolle, M., Piot, P., and van der Groen, G. (1994). Cross-neutralizing antibodies to HIV-1 ANT70 and HIV-1 IIIB in sera of African and Belgian HIV-1 infected individuals. AIDS 8, 1089-1096.
28. Payne, C. D. (1987). GLIM: The GLIM System Release 3.77 Manual, 2nd edition. London: Royal Statistical Society.
29. Profy, A. T., Salinas, P. A., Eckler, L. I., Dunlop, N. M., Nara, P. L., and Putney, S. D. (1990). Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual. Journal of Immunology 144, 4641-4647.
30. Rhodes, P. H., Halloran, M. E., and Longini, I. M. (1996). Counting process models for infectious disease data: Distinguishing exposure to infection from susceptibility. Journal of the Royal Statistical Society, Series B 58, 751-762.
31. Sambamoorthi, N. (1989). Information theoretic criterion approach to dimensionality reduction in multinomial logistic regression models. Part I: Theory. Communications and Statistics 8, 2087-2106.
32. Smith, P. G., Rodrigues, L. C., and Fine, P. E. M. (1984). Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. International Journal of Epidemiology 13, 87-93.
33. SAS. (1990). SAS/STAT User's Guide. SAS Institute: Cary, North Carolina.
34. Szmuness, W., Stevens, C. E., Zang, E. A., Harley, E. J., and Kellner, A. (1981). A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report. Hepatology 1, 377-385.
35. Warren, J. T. and Dolatshahi, M. (1993). First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: Progress in first and second order studies. Journal of Medical Primatology 22, 203-235.
36. Weiss, R. A. (1993). How does HIV cause AIDS? Science 260, 1273-1278.
37. Wilks, S. S. (1938). The large-sample distribution of the likelihood ratio for testing composite hypotheses. Annals of Mathematical Statistics 9, 60-62.
38. Zelen, M. (1991). Multinomial reponse models. Computational Statistics and Data Analysis 12, 249-254.
39. Zwart, G., Wolfs, T. F., Valk, M., Van der Hoek, L., Kuiken, C. L., and Goudsmit, J. (1992). Characterization of the specificity of the human antibody response to the V3 neutralization domain of HIV-1. AIDS Research and Human Retroviruses 8, 1897-1908.